Autonomous cells producing acetyl-lysine offer a novel platform for real-time monitoring of enzyme activity, enhancing ...

The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.

The field of fish conservation is grappling with the complex challenges posed by human-modified landscapes. As habitats undergo rapid transformation due to ...

Researchers have discovered a specific set of neurons in the amygdala that can trigger anxiety and social deficits when ...

Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...

A new study identifies biliverdin reductase A (BVRA) as a crucial enzyme defending neurons from oxidative stress, acting ...

Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

The Council for Scientific and Industrial Research (CSIR) has assured Ghanaians that Genetically Modified (GM) foods, particularly the Pod Borer Resistant (PBR) cowpea, were safe, nutritious, and ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative ...